S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
NASDAQ:MASI

Masimo (MASI) Stock Forecast, Price & News

$139.98
+5.05 (+3.74%)
(As of 05/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$136.50
$140.57
50-Day Range
$112.97
$159.88
52-Week Range
$112.07
$305.21
Volume
1.36 million shs
Average Volume
957,997 shs
Market Capitalization
$7.77 billion
P/E Ratio
36.17
Dividend Yield
N/A
Beta
1
30 days | 90 days | 365 days | Advanced Chart
Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

Masimo logo

About Masimo

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,200
Year Founded
1989

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$4.94 per share
Book Value
$28.00 per share

Profitability

Net Income
$229.65 million
Pretax Margin
21.58%

Debt

Price-To-Earnings

Miscellaneous

Free Float
50,120,000
Market Cap
$7.77 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/03/2022
Today
5/18/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.44 out of 5 stars

Medical Sector

184th out of 1,426 stocks

Electromedical Equipment Industry

4th out of 29 stocks

Analyst Opinion: 4.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -













Masimo (NASDAQ:MASI) Frequently Asked Questions

Is Masimo a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo
or view top-rated stocks.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Masimo
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) posted its quarterly earnings data on Tuesday, May, 3rd. The medical equipment provider reported $0.93 EPS for the quarter, topping the consensus estimate of $0.90 by $0.03. The medical equipment provider had revenue of $304.24 million for the quarter, compared to analyst estimates of $308.04 million. Masimo had a net margin of 17.91% and a trailing twelve-month return on equity of 15.46%. The firm's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.90 earnings per share.
View Masimo's earnings history
.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $4.46-$4.73 for the period, compared to the consensus estimate of $4.16. The company issued revenue guidance of $2.00 billion-$2.06 billion, compared to the consensus revenue estimate of $1.60 billion.

What price target have analysts set for MASI?

6 brokerages have issued 1 year price targets for Masimo's shares. Their forecasts range from $130.00 to $295.00. On average, they expect Masimo's stock price to reach $179.60 in the next year. This suggests a possible upside of 28.3% from the stock's current price.
View analysts' price targets for Masimo
or view top-rated stocks among Wall Street analysts.

Who are Masimo's key executives?
Masimo's management team includes the following people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 57, Pay $4.22M)
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 43, Pay $773.81k) (LinkedIn Profile)
  • Mr. Bilal Muhsin, Chief Operating Officer (Age 41, Pay $986.31k)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 49, Pay $774.53k)
  • Mr. Tao Leopold Levy, Exec. VP of Bus. Devel. (Age 48, Pay $631.6k)
  • Mr. Yongsam Lee, Exec. VP & Chief Information Officer (Age 57)
  • Dr. Steven J. Barker, Chairman of Scientific Advisory Board & Chief Science Officer (Age 77)
  • Mr. Eli Kammerman, VP of Bus. Devel. & Investor Relations
  • Mr. Jon Coleman, Pres of Worldwide Sales, Professional Services & Medical Affairs (Age 58)
  • Mr. Anand Sampath, Exec. VP of Operations & Clinical Research (Age 56)
What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.39%), Vanguard Group Inc. (8.60%), State Street Corp (3.12%), RTW Investments LP (2.03%), Liontrust Investment Partners LLP (1.82%) and Champlain Investment Partners LLC (1.76%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Tao Levy and Thomas Samuel Mcclenahan.
View institutional ownership trends for Masimo
.

Which institutional investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Invesco Ltd., Ownership Capital B.V., Wellington Management Group LLP, California Public Employees Retirement System, TD Asset Management Inc., Capitolis Advisors LLC, and Bank of New York Mellon Corp. Company insiders that have sold Masimo company stock in the last year include Adam Mikkelson, Joe E Kiani, Micah W Young, and Tao Levy.
View insider buying and selling activity for Masimo
or view top insider-selling stocks.

Which institutional investors are buying Masimo stock?

MASI stock was purchased by a variety of institutional investors in the last quarter, including Liontrust Investment Partners LLP, Assenagon Asset Management S.A., Acadian Asset Management LLC, RTW Investments LP, Citigroup Inc., Worldquant Millennium Advisors LLC, Eversept Partners LP, and Goldman Sachs Group Inc..
View insider buying and selling activity for Masimo
or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $139.98.

How much money does Masimo make?

Masimo has a market capitalization of $7.77 billion and generates $1.24 billion in revenue each year. The medical equipment provider earns $229.65 million in net income (profit) each year or $3.869990 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 6,200 workers across the globe.

When was Masimo founded?

Masimo was founded in 1989.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at (949) 297-7000, via email at [email protected], or via fax at 949-297-7001.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.